Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Statins

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies

Akhil Sasidharan, Bhavani Shankara Bagepally, S. Sajith Kumar, Kayala Venkata Jagadeesh, Meenakumari Natarajan

published 16 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical impact of statin intensity according to age in patients with acute myocardial infarction

Kyusup Lee, Myunhee Lee, Dae-Won Kim, Jinseob Kim, Sungmin Lim, Eun Ho Choo, Chan Joon Kim, Chul Soo Park, Hee Yeol Kim, Ki-Dong Yoo, Doo Soo Jeon, Kiyuk Chang, Ho Joong Youn, Wook-Sung Chung, Min Chul Kim, Myung Ho Jeong, Youngkeun Ahn, Jongbum Kwon, Mahn-Won Park

published 15 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK study

Judith J. de Vries, Anouchska S. A. Autar, Dianne H. K. van Dam-Nolen, Samantha J. Donkel, Mohamed Kassem, Anja G. van der Kolk, Twan J. van Velzen, M. Eline Kooi, Jeroen Hendrikse, Paul J. Nederkoorn, Daniel Bos, Aad van der Lugt, Moniek P. M. de Maat, Heleen M. M. van Beusekom

published 09 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy

Yuri Efremov, Anastasia Ermolaeva, Georgiy Vladimirov, Susanna Gordleeva, Andrey Svistunov, Alexey Zaikin, Peter Timashev

published 03 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes

Joyce P. Samuel, Susan H. Wootton, Travis Holder, Donald Molony

published 02 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen

Fahmi Y. Al-Ashwal, Syed Azhar Syed Sulaiman, Siti Maisharah Sheikh Ghadzi, Mohammed Abdullah Kubas, Abdulsalam Halboup

published 26 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome

Roberta Florescu, Elisa Liehn, Nicole Schaaps, Jörg Schröder, Mohammad Almalla, Sebastian Mause, Anne Cornelissen, Felix Vogt

published 19 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Perceived symptoms as the primary indicators for 30-day heart failure readmission

Kelley M. Anderson, Dottie Murphy, Hunter Groninger, Paul Kolm, Haijun Wang, Vera Barton-Maxwel

published 05 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Integrated approach of brachial-ankle pulse wave velocity and cardiovascular risk scores for predicting the risk of cardiovascular events

Hyue Mee Kim, Tae-Min Rhee, Hack-Lyoung Kim

published 27 Apr 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Factors associated with coronary heart disease in COPD patients and controls

Christina D. Svendsen, Karel K. J. Kuiper, Kristoffer Ostridge, Terje H. Larsen, Rune Nielsen, Vidar Hodneland, Eli Nordeide, Per S. Bakke, Tomas M. Eagan

published 27 Apr 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients

Kin Wah Fung, Seo H. Baik, Fitsum Baye, Zhaonian Zheng, Vojtech Huser, Clement J. McDonald

published 18 Apr 2022

Loading metrics information...

Metrics unavailable. Please check back later.

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab

Laura E. Korthauer, Robert P. Giugliano, Jianping Guo, Marc S. Sabatine, Peter Sever, Anthony Keech, Dan Atar, Christopher Kurtz, Christian T. Ruff, Francois Mach, Brian R. Ott

published 11 Apr 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)

Elisa Waldmann, Liya Wu, Kristina Busygina, Julia Altenhofer, Kerstin Henze, Alexander Folwaczny, Klaus G. Parhofer

published 23 Mar 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Statins

You can change these options by clicking profile then "Alerts and Notifications"